Olema Pharmaceuticals experienced a significant decline in its stock price following AstraZeneca's announcement that its Phase 3 SERENA-4 trial did not meet its primary endpoint.…
On August 24, 2026, Wall Street analysts made significant adjustments to their ratings on various companies, including upgrades for AstraZeneca and downgrades for Chipotle Mexican…
Mason Henderson, a 21-year-old diagnosed with a rare brain tumor, faced significant obstacles in obtaining treatment due to insurance coverage issues. Despite his doctors' recomme…
Wall Street concluded the week at record highs, driven by a weaker-than-expected jobs report that eased concerns about imminent Federal Reserve rate hikes. The report revealed a l…